This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Biomx Ltd., Keio University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 362 
Years Active: 2025
Title: Efrat Khabra: Innovator in Bacteriophage Therapy
Introduction
Efrat Khabra is a notable inventor based in Petach Tikva, Israel. She has made significant contributions to the field of medical science, particularly in the area of bacteriophage therapy. Her innovative work focuses on addressing inflammatory bowel disease through the use of bacteriophages.
Latest Patents
Efrat Khabra holds 1 patent for her invention titled "Bacteriophage for modulating inflammatory bowel disease." This patent discloses compositions of bacteriophages and their therapeutic uses. The bacteriophages described in her patent are capable of lysing bacterial strains associated with inflammatory bowel disease, thereby modulating the disease effectively.
Career Highlights
Throughout her career, Efrat has worked with esteemed institutions such as Keio University and Biomx Ltd. Her experience in these organizations has allowed her to advance her research and contribute to the scientific community significantly.
Collaborations
Efrat has collaborated with notable colleagues, including Kenya Honda and Koji Atarashi. These partnerships have enriched her research and expanded the impact of her work in the field of bacteriophage therapy.
Conclusion
Efrat Khabra's innovative approach to treating inflammatory bowel disease through bacteriophage therapy showcases her dedication to advancing medical science. Her contributions are paving the way for new therapeutic options in the treatment of complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile